Cargando…

A Carcinoma of Unknown Primary (CUP) Patient Treated Successfully With Immunotherapy Upon Recognition of Deficient Mismatch Repair Signature on Liquid Biopsy: A Case Report

Carcinoma of unknown primary (CUP) refers to a heterogeneous group of metastatic tumors in which the origin of the tumor is undetermined. Patients with CUP have limited treatment options and an overall poor prognosis. Genomic profiling of the tumor tissue sometimes reveals actionable mutations leadi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Ronald E, Chakrabarti, Sakti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393345/ https://www.ncbi.nlm.nih.gov/pubmed/36017278 http://dx.doi.org/10.7759/cureus.27184

Ejemplares similares

A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy
por: Cox, Ronald E, et al.
Publicado: (2021)

Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’
por: Conway, Alicia-Marie, et al.
Publicado: (2018)

Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

DNA mismatch repair in cancer immunotherapy
por: Guan, Junhong, et al.
Publicado: (2023)

Liquid biopsy for lung cancer immunotherapy
por: Cai, Liang-Liang, et al.
Publicado: (2019)

Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches
por: Laprovitera, Noemi, et al.
Publicado: (2021)

Human DNA mismatch repair: coupling of mismatch recognition to strand-specific excision
por: Wang, Huixian, et al.
Publicado: (2007)

Role of liquid biopsy for thoracic cancers immunotherapy
por: Di Liello, Raimondo, et al.
Publicado: (2020)

Germline genetics of cancer of unknown primary (CUP) and its specific subtypes
por: Hemminki, Kari, et al.
Publicado: (2016)

Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
por: Es, Hamidreza Aboulkheyr, et al.
Publicado: (2021)

The role of DNA mismatch repair in immunotherapy of human cancer
por: He, Yuchen, et al.
Publicado: (2022)

Comparison of diagnostic accuracy of laparoscopic 3 mm and 5 mm cup biopsies to wedge biopsies of canine livers
por: Kimbrell, Tiffany L., et al.
Publicado: (2018)

Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
por: Nagayama, Satoshi, et al.
Publicado: (2021)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
por: Magbanua, Mark Jesus M., et al.
Publicado: (2022)

Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
por: Ao, Huang, et al.
Publicado: (2021)

Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens
por: Grillo, F., et al.
Publicado: (2023)

Insights from the genetic and transcriptional characterization of a cancer of unknown primary (CUP)
por: Davalos, Veronica, et al.
Publicado: (2020)

Mismatch repair dependence of replication stress-associated DSB recognition and repair
por: Fujimori, Haruka, et al.
Publicado: (2019)

Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
por: Viale, Giulia, et al.
Publicado: (2017)

Pediatric Rectal Adenocarcinoma With Mismatch Repair Deficiency Responds to Immunotherapy
por: Qureshi, Naveen, et al.
Publicado: (2023)

Immune escape and resistance to immunotherapy in mismatch repair deficient tumors
por: Mestrallet, Guillaume, et al.
Publicado: (2023)

Implementing liquid biopsies into clinical decision making for cancer immunotherapy
por: Quandt, Dagmar, et al.
Publicado: (2017)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Recognition and binding of mismatch repair proteins at an oncogenic hot spot
por: Edelbrock, Michael, et al.
Publicado: (2005)

Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP
por: Folprecht, Gunnar, et al.
Publicado: (2020)

Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)
por: Lequin, Delphine, et al.
Publicado: (2007)

Cancer of unknown primary (CUP) presenting as a Spigelian hernia: a case report
por: Carollo, Andrea, et al.
Publicado: (2017)

Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?
por: Bochtler, Tilmann, et al.
Publicado: (2019)

Success Factors in the FIFA 2018 World Cup in Russia and FIFA 2014 World Cup in Brazil
por: Lepschy, Hannes, et al.
Publicado: (2021)

Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary
por: Mei, Jie, et al.
Publicado: (2022)

Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma
por: Ebia, Matthew I., et al.
Publicado: (2023)

Carcinoma of Unknown Primary (CUP) versus CUP Turned to Primary Carcinoma of the Head and Neck—An Analysis of Diagnostic Methods and the Impact of Primary Tumor on Clinical Outcome
por: Faisal, Muhammad, et al.
Publicado: (2022)

Survival Outcome in True Carcinoma of Unknown Primary (tCUP) with p16 + Cervical Metastasis
por: Faisal, Muhammad, et al.
Publicado: (2023)

Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective
por: Weiss, L., et al.
Publicado: (2023)

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
por: Wensink, G. Emerens, et al.
Publicado: (2020)

Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
por: Zhao, Junhua, et al.
Publicado: (2009)

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
por: Kim, Yunee, et al.
Publicado: (2016)

A novel microRNA signature for the detection of melanoma by liquid biopsy
por: Sabato, Claudia, et al.
Publicado: (2022)

Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy
por: R., Openshaw M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4kklddctt36ri3vn1kkave762o